OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
): Outsourcing method development offers multiple benefits to companies.
Biologic drugs used in clinical trials need technologies to meet the unique requirements of each study.
Certain high-value sterile dosage forms pose fill/finish challenges due to the small batch sizes
June 23, 2021
Centrient started production at its new statins API manufacturing unit in Toansa, India.
June 22, 2021
Vectura has signed an agreement with Incannex Healthcare for the pre-clinical development of IHL-216A, an inhaled drug product for the treatment of traumatic brain injury.
Thought and foresight into method development stages can ensure costly errors and delays are avoided later on.
June 08, 2021
VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.
AGC Biologics has partnered with BioNTech to further supply plasmid DNA starting material from its Heidelberg, Germany, facility for the Pfizer-BioNTech COVID-19 vaccine.
June 04, 2021
MedPharm’s new facility for process development and small-scale manufacturing is in North Carolina, near its existing R&D center.
June 03, 2021
Automation offers benefits for sterile manufacturing in 503B outsourcing facilities.
June 02, 2021
Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.
May 16, 2021
The sensitivity of droplet digital PCR helps manufacturers detect Mycoplasma contamination in AAV-based gene therapy products.
May 15, 2021
Contract packaging organizations packaging biologic drugs for clinical trials use technologies that meet the unique requirements of each study.